IGF::OT::IGF ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2019. PURPOSE: TO EXERCISE OPTION QUANTITIES 1
IGF::OT::IGF 对非人类灵长类动物模型中潜在药物滥用治疗药物的评估。
基本信息
- 批准号:10038816
- 负责人:
- 金额:$ 171.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-12-16 至 2019-12-15
- 项目状态:已结题
- 来源:
- 关键词:CathetersCocaineCodeDoseExerciseFollow-Up StudiesFoodIntramuscular InjectionsMacaca mulattaModelingNational Institute of Drug AbusePharmaceutical PreparationsProtocols documentationSalineSelf AdministrationStimulusTestingTrainingdrug discriminationmalenonhuman primateresponsesubstance abuse treatment
项目摘要
The main objectives of this project are to determine the effects of compounds using two well-established paradigms: (1) drug discrimination and (2) self-administration. Two distinct experimental protocols, pretreatment and substitution, may be conducted within each paradigm. In the drug discrimination paradigm, male rhesus monkeys will be trained to discriminate an intramuscular injection of cocaine from saline. Subsequently, coded compounds will be studied by determining whether selected doses, administered pre-session, reduce the discriminative-stimulus effects of cocaine (pretreatment) and/or whether selective doses of the compound itself can produce cocaine-like effects (substitution). In the drug self-administration paradigm, Mm will be prepared with indwelling IV catheters, and trained to self-administer IV cocain in daily sessions that also include food self-administration components. Each coded compound will be tested in Mm in which the dose-response function for IV cocaine self-administration has been determined. In the pretreatment protocol, tests will be conducted, first, to identify a pretreatment dose that reduces self-administration of the peak reinforcing unit dose of IV cocaine without greatly altering food self-administration, and second, to determine how that dose alters the cocaine dose response function for IV self-administration. In the substitution protocol, selected unit doses of the coded compound will be made available of IV self-administration to evaluate their reinforcing effects. Follow-up studies may be conducted with promising compounds.
本项目的主要目标是使用两种已确立的范例确定化合物的作用:(1)药物辨别和(2)自我给药。两个不同的实验方案,预处理和替代,可以在每个范例内进行。在药物辨别范例中,将训练雄性恒河猴辨别肌内注射的可卡因和盐水。随后,将通过确定在治疗前给予的选定剂量是否降低可卡因的辨别刺激效应(预处理)和/或化合物本身的选择性剂量是否可以产生可卡因样效应(替代)来研究编码化合物。在药物自我给药模式中,Mm将准备留置IV导管,并接受培训,以在日常会话中自我给药IV可卡因,其中还包括食物自我给药组件。将在Mm中检测每种编码化合物,其中已确定IV可卡因自我给药的剂量-反应函数。在治疗前方案中,将进行试验,首先,确定减少IV可卡因峰值强化单位剂量自我给药而不显著改变食物自我给药的治疗前剂量,其次,确定该剂量如何改变IV自我给药的可卡因剂量反应函数。在替代方案中,将通过IV自我给药提供选定单位剂量的编码化合物,以评价其强化作用。后续研究可能会与有前途的化合物进行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JACK BERGMAN其他文献
JACK BERGMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JACK BERGMAN', 18)}}的其他基金
In vivo characterization of opioid biased agonists
阿片类偏向激动剂的体内表征
- 批准号:
10062935 - 财政年份:2019
- 资助金额:
$ 171.08万 - 项目类别:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
非人类灵长类动物青春期长期接触 THC 的神经、认知和虐待相关后果
- 批准号:
10609878 - 财政年份:2019
- 资助金额:
$ 171.08万 - 项目类别:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
非人类灵长类动物青春期长期接触 THC 的神经、认知和虐待相关后果
- 批准号:
10399441 - 财政年份:2019
- 资助金额:
$ 171.08万 - 项目类别:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
非人类灵长类动物青春期长期接触 THC 的神经、认知和虐待相关后果
- 批准号:
10152566 - 财政年份:2019
- 资助金额:
$ 171.08万 - 项目类别:
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2020.
在非人类灵长类动物模型中评估潜在的药物滥用治疗药物。
- 批准号:
10788187 - 财政年份:2018
- 资助金额:
$ 171.08万 - 项目类别:
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2020.
在非人类灵长类动物模型中评估潜在的药物滥用治疗药物。
- 批准号:
10285326 - 财政年份:2018
- 资助金额:
$ 171.08万 - 项目类别:
IGF::OT::IGF ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2019. PURPOSE: TO EXERCISE OPTION QUANTITIES 1
IGF::OT::IGF 对非人类灵长类动物模型中潜在药物滥用治疗药物的评估。
- 批准号:
10551131 - 财政年份:2018
- 资助金额:
$ 171.08万 - 项目类别:
HEAL - ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2022.
HEAL - 在非人类灵长类动物模型中评估潜在的药物滥用治疗药物。
- 批准号:
10619967 - 财政年份:2018
- 资助金额:
$ 171.08万 - 项目类别:
HEAL - ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2022.
HEAL - 在非人类灵长类动物模型中评估潜在的药物滥用治疗药物。
- 批准号:
10788188 - 财政年份:2018
- 资助金额:
$ 171.08万 - 项目类别:
Pharmacologic Approaches to Prescription Opioid Addiction and Relapse Prevention
处方阿片类药物成瘾和预防复发的药理学方法
- 批准号:
9017987 - 财政年份:2014
- 资助金额:
$ 171.08万 - 项目类别:
相似国自然基金
抗可卡因(Cocaine)抗体酶的研制及实验研究
- 批准号:39570633
- 批准年份:1995
- 资助金额:8.5 万元
- 项目类别:面上项目
相似海外基金
Repurposing Metformin as a Treatment for Cocaine Use Disorder
重新利用二甲双胍治疗可卡因使用障碍
- 批准号:
10823844 - 财政年份:2023
- 资助金额:
$ 171.08万 - 项目类别:
The role of nucleus accumbens dopamine in incubation of cocaine craving
伏隔核多巴胺在可卡因渴望孵化中的作用
- 批准号:
10676025 - 财政年份:2023
- 资助金额:
$ 171.08万 - 项目类别:
Investigate Host Gene Isoforms Contributing to HIV Persistence in Cocaine Users
研究导致可卡因吸食者中艾滋病毒持续存在的宿主基因亚型
- 批准号:
10788990 - 财政年份:2023
- 资助金额:
$ 171.08万 - 项目类别:
Modeling cue-triggered relapse to cocaine use in rats
模拟提示触发大鼠可卡因吸毒复发
- 批准号:
479766 - 财政年份:2023
- 资助金额:
$ 171.08万 - 项目类别:
Operating Grants
Hippocampal mechanisms of cocaine-memory reconsolidation
可卡因记忆重建的海马机制
- 批准号:
10736775 - 财政年份:2023
- 资助金额:
$ 171.08万 - 项目类别:
Targeting Phospholipase C and Dendritic Spines to Reduce Cocaine and Heroin Motivation
靶向磷脂酶 C 和树突棘以减少可卡因和海洛因动机
- 批准号:
10929771 - 财政年份:2023
- 资助金额:
$ 171.08万 - 项目类别:
Nucleus accumbens cholinergic interneurons and cue-induced cocaine craving
伏核胆碱能中间神经元和提示诱导的可卡因渴望
- 批准号:
10738973 - 财政年份:2023
- 资助金额:
$ 171.08万 - 项目类别:
Endocannabinoid regulation of the corticoaccumbens pathway and stress-enhanced cocaine-seeking behavior
内源性大麻素对伏隔皮质通路的调节和压力增强的可卡因寻求行为
- 批准号:
10750394 - 财政年份:2023
- 资助金额:
$ 171.08万 - 项目类别:
TASK ORDER 01 COCAINE INTERACTION SAFETY STUDIES IN RATS. TOXICOLOGICAL EVALUATIONS OF POTENTIAL MEDICATIONS IDIQ. ORDERING PERIOD: 09/12/2023 - 09/11/2024. NIDA REF. NO. N01DA-23-8939
任务单 01 可卡因相互作用在大鼠中的安全性研究。
- 批准号:
10947939 - 财政年份:2023
- 资助金额:
$ 171.08万 - 项目类别:
Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase
使用 Cav3 通道和可溶性环氧化物水解酶的 IND 双重抑制剂开发可卡因使用障碍的新型治疗方法
- 批准号:
10786151 - 财政年份:2023
- 资助金额:
$ 171.08万 - 项目类别: